Insitro

Insitro is the operator of a data-driven drug discovery and development company that uses machine learning and high-throughput biology to transform the way drugs are discovered and delivered to patients. The company uses state-of-the-art technologies from bioengineering, enabling it to generate high-throughput and functional genomic datasets and align them with patient data via novel machine learning methods, thereby building predictive models that can accelerate target selection and the design and development of effective therapeutics.